Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Cancer Immunology Essentials
    • Collections
      • COVID-19 & Cancer Resource Center
      • "Best of" Collection
      • Editors' Picks
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Immunology Research
Cancer Immunology Research
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Cancer Immunology Essentials
    • Collections
      • COVID-19 & Cancer Resource Center
      • "Best of" Collection
      • Editors' Picks
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Research Articles

Enhancement of Tumor-Reactive Cytotoxic CD4+ T-cell Responses after Ipilimumab Treatment in Four Advanced Melanoma Patients

Shigehisa Kitano, Takemasa Tsuji, Caillian Liu, Daniel Hirschhorn-Cymerman, Chrisann Kyi, Zhenyu Mu, James P. Allison, Sacha Gnjatic, Jianda D. Yuan and Jedd D. Wolchok
Shigehisa Kitano
1Ludwig Center for Cancer Immunotherapy, Immunology Program, 2Department of Medicine, 3Swim Across America Laboratory, and Ludwig Institute for Cancer Research, Memorial Sloan-Kettering Cancer Center; 4Weill Cornell Medical College of Cornell University; and 5Mount Sinai Icahn School of Medicine, Tisch Cancer Institute, New York; and 6Center for Immunotherapy, Roswell Park Cancer Institute, Buffalo, New York; 7Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, Texas
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Takemasa Tsuji
1Ludwig Center for Cancer Immunotherapy, Immunology Program, 2Department of Medicine, 3Swim Across America Laboratory, and Ludwig Institute for Cancer Research, Memorial Sloan-Kettering Cancer Center; 4Weill Cornell Medical College of Cornell University; and 5Mount Sinai Icahn School of Medicine, Tisch Cancer Institute, New York; and 6Center for Immunotherapy, Roswell Park Cancer Institute, Buffalo, New York; 7Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, Texas
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Caillian Liu
1Ludwig Center for Cancer Immunotherapy, Immunology Program, 2Department of Medicine, 3Swim Across America Laboratory, and Ludwig Institute for Cancer Research, Memorial Sloan-Kettering Cancer Center; 4Weill Cornell Medical College of Cornell University; and 5Mount Sinai Icahn School of Medicine, Tisch Cancer Institute, New York; and 6Center for Immunotherapy, Roswell Park Cancer Institute, Buffalo, New York; 7Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, Texas
1Ludwig Center for Cancer Immunotherapy, Immunology Program, 2Department of Medicine, 3Swim Across America Laboratory, and Ludwig Institute for Cancer Research, Memorial Sloan-Kettering Cancer Center; 4Weill Cornell Medical College of Cornell University; and 5Mount Sinai Icahn School of Medicine, Tisch Cancer Institute, New York; and 6Center for Immunotherapy, Roswell Park Cancer Institute, Buffalo, New York; 7Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, Texas
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Daniel Hirschhorn-Cymerman
1Ludwig Center for Cancer Immunotherapy, Immunology Program, 2Department of Medicine, 3Swim Across America Laboratory, and Ludwig Institute for Cancer Research, Memorial Sloan-Kettering Cancer Center; 4Weill Cornell Medical College of Cornell University; and 5Mount Sinai Icahn School of Medicine, Tisch Cancer Institute, New York; and 6Center for Immunotherapy, Roswell Park Cancer Institute, Buffalo, New York; 7Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, Texas
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chrisann Kyi
1Ludwig Center for Cancer Immunotherapy, Immunology Program, 2Department of Medicine, 3Swim Across America Laboratory, and Ludwig Institute for Cancer Research, Memorial Sloan-Kettering Cancer Center; 4Weill Cornell Medical College of Cornell University; and 5Mount Sinai Icahn School of Medicine, Tisch Cancer Institute, New York; and 6Center for Immunotherapy, Roswell Park Cancer Institute, Buffalo, New York; 7Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, Texas
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zhenyu Mu
1Ludwig Center for Cancer Immunotherapy, Immunology Program, 2Department of Medicine, 3Swim Across America Laboratory, and Ludwig Institute for Cancer Research, Memorial Sloan-Kettering Cancer Center; 4Weill Cornell Medical College of Cornell University; and 5Mount Sinai Icahn School of Medicine, Tisch Cancer Institute, New York; and 6Center for Immunotherapy, Roswell Park Cancer Institute, Buffalo, New York; 7Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, Texas
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
James P. Allison
1Ludwig Center for Cancer Immunotherapy, Immunology Program, 2Department of Medicine, 3Swim Across America Laboratory, and Ludwig Institute for Cancer Research, Memorial Sloan-Kettering Cancer Center; 4Weill Cornell Medical College of Cornell University; and 5Mount Sinai Icahn School of Medicine, Tisch Cancer Institute, New York; and 6Center for Immunotherapy, Roswell Park Cancer Institute, Buffalo, New York; 7Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, Texas
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sacha Gnjatic
1Ludwig Center for Cancer Immunotherapy, Immunology Program, 2Department of Medicine, 3Swim Across America Laboratory, and Ludwig Institute for Cancer Research, Memorial Sloan-Kettering Cancer Center; 4Weill Cornell Medical College of Cornell University; and 5Mount Sinai Icahn School of Medicine, Tisch Cancer Institute, New York; and 6Center for Immunotherapy, Roswell Park Cancer Institute, Buffalo, New York; 7Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, Texas
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jianda D. Yuan
1Ludwig Center for Cancer Immunotherapy, Immunology Program, 2Department of Medicine, 3Swim Across America Laboratory, and Ludwig Institute for Cancer Research, Memorial Sloan-Kettering Cancer Center; 4Weill Cornell Medical College of Cornell University; and 5Mount Sinai Icahn School of Medicine, Tisch Cancer Institute, New York; and 6Center for Immunotherapy, Roswell Park Cancer Institute, Buffalo, New York; 7Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, Texas
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jedd D. Wolchok
1Ludwig Center for Cancer Immunotherapy, Immunology Program, 2Department of Medicine, 3Swim Across America Laboratory, and Ludwig Institute for Cancer Research, Memorial Sloan-Kettering Cancer Center; 4Weill Cornell Medical College of Cornell University; and 5Mount Sinai Icahn School of Medicine, Tisch Cancer Institute, New York; and 6Center for Immunotherapy, Roswell Park Cancer Institute, Buffalo, New York; 7Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, Texas
1Ludwig Center for Cancer Immunotherapy, Immunology Program, 2Department of Medicine, 3Swim Across America Laboratory, and Ludwig Institute for Cancer Research, Memorial Sloan-Kettering Cancer Center; 4Weill Cornell Medical College of Cornell University; and 5Mount Sinai Icahn School of Medicine, Tisch Cancer Institute, New York; and 6Center for Immunotherapy, Roswell Park Cancer Institute, Buffalo, New York; 7Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, Texas
1Ludwig Center for Cancer Immunotherapy, Immunology Program, 2Department of Medicine, 3Swim Across America Laboratory, and Ludwig Institute for Cancer Research, Memorial Sloan-Kettering Cancer Center; 4Weill Cornell Medical College of Cornell University; and 5Mount Sinai Icahn School of Medicine, Tisch Cancer Institute, New York; and 6Center for Immunotherapy, Roswell Park Cancer Institute, Buffalo, New York; 7Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, Texas
1Ludwig Center for Cancer Immunotherapy, Immunology Program, 2Department of Medicine, 3Swim Across America Laboratory, and Ludwig Institute for Cancer Research, Memorial Sloan-Kettering Cancer Center; 4Weill Cornell Medical College of Cornell University; and 5Mount Sinai Icahn School of Medicine, Tisch Cancer Institute, New York; and 6Center for Immunotherapy, Roswell Park Cancer Institute, Buffalo, New York; 7Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, Texas
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1158/2326-6066.CIR-13-0068 Published October 2013
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Online Impact

Statistics from Altmetric.com

ARTICLE USAGE

ARTICLE USAGE: August 2013 to January 2021

AbstractFull-text HTMLPDF
Total372423942333

Cited By

Article Information

Volume 1, Issue 4, pp. 235-244

DOI 
https://doi.org/10.1158/2326-6066.CIR-13-0068
PubMed 
24396833

Published By 
American Association for Cancer Research
Print ISSN 
2326-6066
Online ISSN 
2326-6074
History 
  • Received May 31, 2013
  • Revision received August 2, 2013
  • Accepted August 5, 2013
  • Published first August 12, 2013.

Article Versions

  • Previous version (August 12, 2013 - 05:43).
  • Previous version (September 5, 2013 - 07:28).
  • You are viewing the most recent version of this article.
Copyright & Usage 
©2013 American Association for Cancer Research.

Author Information

  1. Shigehisa Kitano1,
  2. Takemasa Tsuji6,
  3. Caillian Liu1,3,
  4. Daniel Hirschhorn-Cymerman3,
  5. Chrisann Kyi4,
  6. Zhenyu Mu1,
  7. James P. Allison7,
  8. Sacha Gnjatic5,
  9. Jianda D. Yuan1, and
  10. Jedd D. Wolchok1,2,3,4
  1. Authors' Affiliations: 1Ludwig Center for Cancer Immunotherapy, Immunology Program, 2Department of Medicine, 3Swim Across America Laboratory, and Ludwig Institute for Cancer Research, Memorial Sloan-Kettering Cancer Center; 4Weill Cornell Medical College of Cornell University; and 5Mount Sinai Icahn School of Medicine, Tisch Cancer Institute, New York; and 6Center for Immunotherapy, Roswell Park Cancer Institute, Buffalo, New York; 7Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, Texas
  1. Corresponding Author:
    Jedd D. Wolchok, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10065. Phone: 646-888-2395; Fax: 646-422-0453; E-mail: wolchokj{at}mskcc.org
View Full Text
PreviousNext
Back to top
Cancer Immunology Research: 1 (4)
October 2013
Volume 1, Issue 4
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover

Sign up for alerts

View this article with LENS

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Immunology Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Enhancement of Tumor-Reactive Cytotoxic CD4+ T-cell Responses after Ipilimumab Treatment in Four Advanced Melanoma Patients
(Your Name) has forwarded a page to you from Cancer Immunology Research
(Your Name) thought you would be interested in this article in Cancer Immunology Research.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Enhancement of Tumor-Reactive Cytotoxic CD4+ T-cell Responses after Ipilimumab Treatment in Four Advanced Melanoma Patients
Shigehisa Kitano, Takemasa Tsuji, Caillian Liu, Daniel Hirschhorn-Cymerman, Chrisann Kyi, Zhenyu Mu, James P. Allison, Sacha Gnjatic, Jianda D. Yuan and Jedd D. Wolchok
Cancer Immunol Res October 1 2013 (1) (4) 235-244; DOI: 10.1158/2326-6066.CIR-13-0068

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Enhancement of Tumor-Reactive Cytotoxic CD4+ T-cell Responses after Ipilimumab Treatment in Four Advanced Melanoma Patients
Shigehisa Kitano, Takemasa Tsuji, Caillian Liu, Daniel Hirschhorn-Cymerman, Chrisann Kyi, Zhenyu Mu, James P. Allison, Sacha Gnjatic, Jianda D. Yuan and Jedd D. Wolchok
Cancer Immunol Res October 1 2013 (1) (4) 235-244; DOI: 10.1158/2326-6066.CIR-13-0068
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Disclosure of Potential Conflicts of Interest
    • Authors' Contributions
    • Grant Support
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • CD28 Mutation Enhances CAR T-cell Function
  • ICV-Delivered CD19-CAR T Cells for CNS and Systemic Lymphoma
  • Activin A Mediates Radiation-Induced Antitumor Immunity
Show more Research Articles
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook   Twitter   LinkedIn   YouTube   RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Cancer Immunology Essentials

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Cancer Immunology Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Cancer Immunology Research
eISSN: 2326-6074
ISSN: 2326-6066

Advertisement